You searched for "New Zealand"

69 results found

Oertli Instrumente AG wins the Swiss Medtech Award

Oertli Instrumente AG has been honored with the prestigious Swiss Medtech Award, worth CHF 75,000 at the Swiss Medtech Day.

Aflibercept (AF) for age-related macular degeneration (ARMD): four-year outcomes of a ‘’treat-and-extend’ (T&E) regimen with exit-strategy

This is a retrospective observational study of 82 patients, between 2014 to 2016 from Switzerland of treatment-naive patients with nARMD, treated with AF, with specific T&E protocol without a loading phase and predefined exit criteria and patients were observed three...

Complement factor B polymorphism and the phenotype of early age-related macular degeneration

The relationship between complement factor H (CFH) and age-related macular degeneration (AMD) is very well known, but other genetic polymorphisms relating to AMD are more poorly understood. This study was designed to investigate the relationship between complement factor B (CFB)...

Online submissions open for NCC contact lens congress

Online submissions for a collaborative research symposium to be held as part of Europe’s biggest eye health conference are now open.

Eye News to partner with AOP Young Ophthalmologists Program

We are delighted to announce our partnership with the AOP (Advanced Ophthalmologic Practice) Academy Young Ophthalmologists event 'Retina: How to avoid false friends'.

Does cornea cross-linkage reduce the rate of corneal transplants in keratoconus?

Cornea cross-linking (CXL) is a relatively new treatment in the management of keratoconus, which may help prevent the need for corneal transplant. This paper investigates if the introduction of corneal cross-linkage has reduced the number of corneal transplants performed annually...

Driving with the use of spectacle mounted telescopes (bioptics)

The authors discuss the current perspectives of spectacle mounted telescopes (bioptics) whilst driving among patients with visual impairment. The history, design and driving laws surrounding the use of bioptics is discussed in detail. In 1977, William Feinbloom developed a bioptic...

Good News from Switzerland: A History of Retinal Reattachment Surgery

In one concise volume the reader learns of the recent rapid evolution in vitreoretinal (VR) surgery. The pioneering innovators were often remarkable personalities and this book helps to bring them to life. Prior to 1929 victims of retinal detachment were...

Licence to save: a UK survey of anti-VEGF use for the eye

This comment article highlights the controversy that exists in the choice for anti-VEGF drugs used for treatment of macular oedema and wet age-related macular degeneration (AMD). Two existing licensed drugs for macular oedema are ranibizumab (Lucentis) and aflibercept (Eylea). A...

UK rejoins Horizon Europe research funding programme

The UK government has announced that it will rejoin the €95bn Horizon Europe research framework.

WHO SPECS 2030: a global initiative to strengthen refractive error services

Globally, it is estimated that only around one-third of people with vision impairment due to refractive error have received access to a quality pair of spectacles [1]. In recognition that uncorrected refractive error is the leading cause of vision impairment...

Update on emerging therapies for age-related macular degeneration

The 23rd European Society of Retina Specialists (EURETINA) Congress, held in Amsterdam, the Netherlands, provided a timely update on anti-complement therapy for geographic atrophy and emerging investigational therapies for neovascular age-related macular degeneration. Anti-complement therapy for geographic atrophy Geographic atrophy...